Structured evidence table for Peppermint Gut Symptoms Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Peppermint Gut Symptoms Randomized Trial | Irritable bowel syndrome (IBS) is a common disorder of brain-gut interaction that presents with abdominal pain, bloating associated with variable stool consistency. | 1 | Meyer A (2026) | Systematic Review and Meta-Analysis: Plant-Based Therapy for Irritable Bowel Syndrome. |
| Peppermint Gut Symptoms Randomized Trial | Many IBS patients prefer plant-based preparations to pharmacological therapy; however, the utility of this approach is not well established. | 1 | Meyer A (2026) | Systematic Review and Meta-Analysis: Plant-Based Therapy for Irritable Bowel Syndrome. |
| Peppermint Gut Symptoms Randomized Trial | Results During treatment, all assessed abdominal symptoms showed significant (p Conclusion The study demonstrates patient-relevant improvement in gastrointestinal symptoms during treatment with Menthacarin while underlining its favorable tolerability profile. | 2 | Linas I (2025) | Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial. |
| Peppermint Gut Symptoms Randomized Trial | Introduction In disorders of gut-brain interaction including functional dyspepsia and irritable bowel syndrome, clinical focus has shifted from pathophysiological criteria to symptoms. | 2 | Linas I (2025) | Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial. |
| Peppermint Gut Symptoms Randomized Trial | Methods A single-arm, low-intervention clinical trial into the effectiveness and tolerability of Menthacarin, a peppermint oil/caraway oil combination, was performed. | 2 | Linas I (2025) | Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial. |
Source documents